-
Data and information
(39)
- Outcomes (2)
-
Conditions
(16)
- Dental (1)
- Mental and behavioural (2)
- Chronic (1)
- Genitourinary system (1)
- Infectious disease (2)
- Fertility, obstetrics and gynaecology (1)
- Respiratory system (1)
- Cardiovascular system (3)
- Brain and Nervous System (1)
- Congenital malformations, deformations and chromosomal abnormalities (4)
- Cancer (14)
- Metabolic and Nutrition (3)
- Health and Social Care (39)
- People and Places (8)
- Technology and Architecture (1)
- Service Types (7)
- Service catalogue (1)
- Content Types (2)
- Country (25)
- Primary Care Organisations (18)
- Strategic Health Authorities (17)
- Regions (9)
- Local Authorities (8)
- Government Office Regions (3)
- Local Authorities (2)
- Clinical Commissioning Groups (2)
- Primary Care Trusts (2)
- Clinical Commissioning Groups (1)
- County (1)
- Local Authorities (1)
- London Authorities (1)
- ONS Area Classification (1)
- Primary Care Organisations (1)
- Regions (1)
- Strategic Health Authorities (1)
- Clinical Commissioning Regions (1)
- Show all (18) Show less
Search results
The National Disease Registration Service (NDRS) is the data partner for the ongoing trials in England evaluating the effectiveness of the Galleri® blood test in detecting cancer at an early stage.
The Cancer Services profiles tool on Fingertips provides data for a number of indicators focussed on cancer-related activity relevant to primary care.
The Breast screening After Radiotherapy Dataset (BARD) helps to optimise screening for women who may be at higher risk of developing a second primary cancer.
This indicator measures the coverage of the screening programme. For the years of data available, this is the proportion of women aged between 53 and 64 who are resident (excluding those ineligible e.g. those who have had a bilateral mastectomy) who have had a test with a recorded result at least once...